ESGE DAYS 2026

14-15 May 2026
Auditorium Testori - MILANO

RES

TYPOLOGY

RES

FREE

DATE

14/05/2026

END DATE

15/05/2026
Sign in to join the course

Scientific rationale

On the occasion of ESGE Days 2026, the SIED – Italian Society of Digestive Endoscopy, in collaboration with ESGE – European Society of Gastrointestinal Endoscopy and with the support of Lombardy Region, promotes an awareness project dedicated to the prevention of colorectal cancer.

colorectal carcinoma is still one of the main causes of cancer mortality in the world. Particularly worrying is the growing increase in cases in younger population groups, with about 1 out of 10 diagnoses in people under 50 years. This scenario makes it increasingly urgent to spread a culture of prevention and risk awareness.

The adoption of healthy lifestyles – balanced nutrition, body weight control, regular physical activity, alcohol reduction and smoking abolition – can significantly contribute to the prevention of numerous neoplasms, including colorectal cancer. In this context, prevention and early diagnosis take a decisive role.

The project puts the citizen at the centre of the information path through initiatives aimed at young people and the general population: educational meetings in schools, multidisciplinary events and innovative experiences of augmented immersive reality, which allow to explore the human colon and understand in a simple and engaging way the role of microbiota, food and polipi formation.

The goal is to create a stable and replicable model of collaboration between institutions and scientific societies, able to strengthen the national campaign of prevention of colorectal cancer, improve public health protection and contribute to the sustainability of the healthcare system.

A City Fun Run, open to citizens and congress participants, is also planned to promote physical activity as a fundamental element of prevention.

WITH THE PATROCINIUS OF

START
14 May 2026
END OF COURSE
15 May 2026
TYPOLOGY
RES
LOCATION
Auditorium Testori - MILANO
PARTICIPANTS
100
E-MAIL
info@studio-congressi.com
Studio Congressi s.r.l.
VAT: 01975530187
Reg. Companies of Pv: 01975530187
R.E.A.: 235792
Social Capital: € 260.000,00

Studio Congressi s.r.l. and Med Tech Science s.r.l.
Avenue of Liberty, 17 | 27100 Pavia (PV)
📞 +39.0382.21424 | +39.351.8055151
info@studio-congressi.com
medtechscience2@gmail.com
Code Recipient SDI BA6ET11

Med Tech Science Ltd.
VAT No: 02080160183
Reg. Pv: 02080160183
R.E.A.: 244029
Social Capital: € 100,000,00

Studio Congressi s.r.l. and Med Tech Science s.r.l.
Avenue of Liberty, 17 | 27100 Pavia (PV)
📞 +39.0382.21424 | +39.351.8055151
info@studio-congressi.com
medtechscience2@gmail.com
Code Recipient SDI BA6ET11

Studio Congressi s.r.l.
VAT: 01975530187
Reg. Companies of Pv: 01975530187
R.E.A.: 235792
Social Capital: € 260.000,00

Med Tech Science Ltd.
VAT No: 02080160183
Reg. Pv: 02080160183
R.E.A.: 244029
Social Capital: € 100,000,00

SLEEVE GASTRECTOMY
AND BEYOND:

Surgical Technique
& Technologies Update

February 12 - 13, 2026
Health Campus - PAVIA

RES

TYPOLOGY

RES

FREE

DATE

12/02/2026

END DATE

13/02/2026
Sign in to join the course

Scientific rationale

The sleeve gastrectomy has been the world’s most successful surgery in the field of barytric surgery for many years and represents alone about the 60% of all bariatricprocedures performed every year. Despite the widespread spread of the procedure, we are still far from achieving a standard shared from the point of view of surgical technique. Literature data shows that the rate of complications, effectiveness, comorbidity resolution and gastroesophageal reflux varies greatly in different centers and latitudes in the world. This reflects the fact that, in addition to the problem of follow-up – fundamental to achieve good results in the medium-long period – probably when we say "sleeve gastrectomy" we often refer to an ideal procedure that then, in practice, can be freely interpreted in some passages. Parallel to the bariatric surgery, in recent years the bariatric endoscopy has also developed. Endoscopy Sleep Gastroplasty its main expression. The two options are not to be considered as "competition", but rather as the possibility of offering a personalized treatment based on the different factors in play. In this context, collaboration and cooperation is fundamental, possibly within paths shared by a multidisciplinary team. This meeting of experts wants to compare different operational approaches, endoscopic surgery, to stimulate a discussion that can lead to the acquisition of greater certainty and, if possible, try to approach the definition of "standard procedure". In addition, a significant space will be devoted to endoscopic treatment of complications, a true life-saving for our patients who, unfortunately, should develop the fistolous complication in the post-operative period.

CONTRIBUTION

 

START
12 February 2026
END OF COURSE
13 February 2026
TERMINATION
05 February 2026
TYPOLOGY
RES
LOCATION
Health Campus - PAVIA
PARTICIPANTS
20
TARGETS
SURRGES

REFERENCE SPIPLINES:
GENERAL SURUGIA - BARIATRIC SURUGIA - TORACIC SURUGIA - VASCULAR SURUGIA - ONCELOGY
ECM ID
752 - 472590
N. CREDITS RES
7
REGISTERING QUOTA
Free
CODE EVENT
CHAPTER
E-MAIL
address:
Studio Congressi s.r.l.
VAT: 01975530187
Reg. Companies of Pv: 01975530187
R.E.A.: 235792
Social Capital: € 260.000,00

Studio Congressi s.r.l. and Med Tech Science s.r.l.
Avenue of Liberty, 17 | 27100 Pavia (PV)
📞 +39.0382.21424 | +39.351.8055151
info@studio-congressi.com
medtechscience2@gmail.com
Code Recipient SDI BA6ET11

Med Tech Science Ltd.
VAT No: 02080160183
Reg. Pv: 02080160183
R.E.A.: 244029
Social Capital: € 100,000,00

Studio Congressi s.r.l. and Med Tech Science s.r.l.
Avenue of Liberty, 17 | 27100 Pavia (PV)
📞 +39.0382.21424 | +39.351.8055151
info@studio-congressi.com
medtechscience2@gmail.com
Code Recipient SDI BA6ET11

Studio Congressi s.r.l.
VAT: 01975530187
Reg. Companies of Pv: 01975530187
R.E.A.: 235792
Social Capital: € 260.000,00

Med Tech Science Ltd.
VAT No: 02080160183
Reg. Pv: 02080160183
R.E.A.: 244029
Social Capital: € 100,000,00